Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marta Petullà"'
Autor:
Gabriella Mometto, Angela Passi, Chiara Cattaneo, Elisabetta Todisco, Annamaria Nosari, Patrizia Zappasodi, Luisa Verga, V. Saccà, Valentina Mancini, Andrea Ferrario, Samantha Ferrari, M C Da Via, Marta Petullà, Giorgio Rossi, Cristina Skert, Claudio Annaloro, Francesca Pavesi
Publikováno v:
Annals of Hematology. 95:1955-1963
Multiresistant bacterial infections are a potentially life-threatening condition in acute leukaemia (AL) patients. We aimed to better define the very recent epidemiology and outcome of bloodstream infections (BSIs) in a real-life setting. We prospect
Autor:
Nicola Stefano Fracchiolla, Giuseppe Rossi, Mauro Turrini, Roberto Cairoli, Armando Santoro, Claudia Basilico, Federico Serana, Elisa Sala, Matteo Claudio Da Via, Carlo Castagnola, Agostino Cortelezzi, Massimo Bernardi, Elisabetta Todisco, Andrea Ferrario, Patrizia Zappasodi, Chiara Pagani, Erika Borlenghi, Valentina Mancini, Marta Petullà, Chiara Cattaneo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0dda444cf8d444f713f495047415b25
https://hdl.handle.net/10281/408818
https://hdl.handle.net/10281/408818
Autor:
Chiara Cattaneo, Marta Petullà, Elisa Cerqui, Giuseppe Rossi, Alessandro Re, Francesca Antoniazzi, Chiara Pagani, Erika Borlenghi, Mario Tumbarello, Francesca Schieppati, Cristina Skert
Publikováno v:
Annals of Hematology. 93:785-790
Acute leukemia (AL) patients may experience more than one episode of bloodstream infection (BSI) caused by the same pathogen during the entire chemotherapy program. In order to identify factors influencing BSI recurrence (R-BSI) during subsequent pha
Autor:
Marina Motta, Antonella Anastasia, Samantha Ferrari, Giuseppe Rossi, Gloria Valimberti, Marta Petullà, Angela Passi, Chiara Bottelli, Alessandra Tucci
Publikováno v:
Blood. 132:5328-5328
Introduction: Advanced stage follicular lymphoma (FL) is generally considered incurable. Although multiple remissions after treatment are possible, relapse is considered the rule, and the time to progression tends to become shorter after each relapse
Autor:
Angela Passi, Chiara Cattaneo, Cinzia Lamorgese, Marta Petullà, Giuseppe Rossi, Annafranca Panzali, Luigi Caimi, Alessandro Re, Erika Borlenghi
Publikováno v:
Mycoses. 58(6)
The usefulness of posaconazole therapeutic drug monitoring (TDM) is still a matter of debate. A correlation between posaconazole serum levels and breakthrough invasive fungal infections (IFI) has not been clearly demonstrated so far. We analysed posa
Autor:
Simona Fisogni, Salvatore Casari, Vilma Pellegrini, Chiara Cattaneo, Marta Petullà, Filippo Castelnuovo, Silvia Lonardi, Marco Ungari, Annalisa Peli, Fabio Facchetti, Alessandro Re, Giuseppe Rossi
Plasmablastic lymphoma (PBL) is a recently introduced entity, with a particularly aggressive clinical behavior among human immunodeficiency virus-positive (HIV-pos) patients [1], and with a predile...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9049f7bf3a3385b9e6c5ca6c0af422d
http://hdl.handle.net/11379/383908
http://hdl.handle.net/11379/383908
Autor:
Giuseppina Ruggeri, Marta Petullà, Giuseppe Rossi, Vincenza Orlando, Chiara Pagani, Erika Borlenghi, Chiara Cattaneo, Angela Passi, Angelo Belotti, Elisa Cerqui, Mirko Farina
Publikováno v:
Blood. 128:3993-3993
Introduction: Postremission treatment in adult acute myeloid leukemia (AML) is mandatory to improve long-term remission duration. Allogeneic stem-cell transplantation (allo-SCT) is considered gold standard in younger patients (pts) with higher risk o
Autor:
Adriano Salaroli, Agostino Cortelezzi, Angela Melpignano, Maria D Caputo, Alfonso Piciocchi, Candida Vitale, Francesca Re, Paola Fazi, Carlo Visco, Francesca Romana Mauro, Anna Maria Frustaci, Robin Foà, Livio Trentin, Marco Vignetti, Alessandra Tedeschi, Giuseppe Tagariello, Marta Coscia, Monica Tani, Alessandro Gozzetti, Paolo de Fabritiis, Marina Motta, Lucia Farina, Donatella Vincelli, Catello Califano, Roberto Marasca, Luca Laurenti, Idanna Innocenti, Ester Orlandi, Alessandro Andriani, Paolo Ghia, Emilia Iannella, Lydia Scarfò, Marta Petullà, Stefano Molica, Pier Luigi Zinzani
Publikováno v:
Blood. 128:2038-2038
Introduction. Observational studies from patients treated outside controlled clinical trials offer real life information and are relevant to understand whether data derived from prospective trials are reproducible in the clinical practice. A retrospe
Autor:
Claudia Ghidini, Alessandra Tucci, Chiara Pagani, Marta Petullà, Luisa Imberti, Marina Motta, Marco Chiarini, Antonella Anastasia, Viviana Giustini, Samantha Ferrari, Giuseppe Rossi, Marion Vaglio Tessitore
Publikováno v:
Blood. 126:1531-1531
Introduction Phosphoinositide-3-kinases (PI3Ks) are pivotal in various cellular functions including proliferation and survival, cell differentiation, intracellular trafficking and immunity. The PI3Kδ isoform is highly expressed in cells of hematopoi
Autor:
Enrico Morello, Alessandra Tucci, Raffaele Giubbini, Alessandro Re, Marta Petullà, Giancarlo Magri, Giuseppe Rossi, Antonella Anastasia, Chiara Pagani, Marina Motta
Publikováno v:
Blood. 124:4455-4455
Introduction: XPO1 (CRM1, Exportin 1) is the sole transporter of many tumor suppressor proteins (including MYC, BCL2, BCL6, BTK, IkB) and is elevated in non-Hodgkin Lymphoma. Selinexor (Sel, KPT-330) is an oral covalent inhibitor of XPO1, the first c